Search results
Choppy times for firms must end, says lobby group
BBC via Yahoo Finance· 10 hours ago[Getty] A lobby body representing thousands of UK firms has urged the next government to forge closer ties with the EU after years of ...
Dallas dreams of cricket
ESPN· 14 hours agoIn four words, you have the summary of why Texas has become the hub of cricket in America. "It's not even a question ...
Research reveals that more people died from hot or cold weather conditions than COVID-19 in parts of...
Medical Xpress· 7 days agoThe researchers sprang into action after Sir Patrick Vallance, the UK Government's former Chief Scientific Adviser, highlighted...
How therapeutics could transform our response to the next pandemic
Daily Telegraph· 6 hours agoFour years on from the pandemic, in the global north, vaccines remain the jewel in< ...
World Health Organization overturns dogma on airborne diseases, but the CDC may not act on it
Daily Montanan via Yahoo News· 3 days agoThe World Health Organization has issued a report that transforms how the world understands...
US poised to invest millions in mRNA bird flu vaccine amid H5N1 scare
The Telegraph via Yahoo News· 2 hours agoThe US government is poised to announce a multimillion-dollar investment in mRNA vaccines for H5N1...
Human Capital for the Age of Generative AI | by Simon Johnson & Eric Hazan - Project Syndicate
Project Syndicate· 9 hours agoGenerative artificial intelligence has captured the world’s imagination because it appears likely to...
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 7 days agoA rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in
Sue Gray - Latest News, Pictures, Comment and Updates | Express.co.uk
Daily Express· 1 day agoGet the latest news and breaking updates on Sue Gray
Merck to buy eye-focused drug developer EyeBio for as much as $3 billion
Reuters via Yahoo Finance· 1 day ago(Reuters) -Merck on Wednesday agreed to buy privately held biotech EyeBio for as much as $3 billion,...